Skip to main content
Fig. 2 | Journal of Experimental & Clinical Cancer Research

Fig. 2

From: CXCL12/CXCR4 promotes inflammation-driven colorectal cancer progression through activation of RhoA signaling by sponging miR-133a-3p

Fig. 2

CXCR4+/−Apcmin/+ compound mutant mice exhibited more tumor load than Apcmin/+ mice. a The schematic regimen of inflammatory cancer in Apcmin/+ and CXCR4+/−Apcmin/+ mice by treatment with 3 cycles of 1% DSS. b Apcmin/+ and CXCR4+/−Apcmin/+ mice (aged at 12 weeks, n = 15) were treated with or without 3 cycles of 1% DSS. At age of 30 weeks, the mice were sacrificed and representative images of intestine polyps were shown. c Average number and size of polyps of colon and small intestine were determined and statistical analysis was performed (n = 5 for each group). *P < 0.05 vs. Apcmin/+ mice. #P < 0.05 vs. Apcmin/+ and CXCR4+/−Apcmin/ +mice respectively as indicated. d Representative H&E staining of colonic tumors (n = 5 for each group)

Back to article page